Provided by Tiger Trade Technology Pte. Ltd.

Monopar Therapeutics

58.25
-2.0250-3.36%
Volume:164.75K
Turnover:9.51M
Market Cap:389.23M
PE:-19.48
High:59.26
Open:59.15
Low:55.34
Close:60.27
52wk High:105.00
52wk Low:26.06
Shares:6.68M
Float Shares:4.93M
Volume Ratio:1.58
T/O Rate:3.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9895
EPS(LYR):-4.1123
ROE:-26.54%
ROA:-17.99%
PB:2.75
PE(LYR):-14.16

Loading ...

Monopar Therapeutics Inc.: Promising Prospects with ALXN1840 Acquisition and Wilson’s Disease Market Potential

TIPRANKS
·
Oct 10, 2025

Monopar Therapeutics Is Maintained at Strong Buy by Raymond James

Dow Jones
·
Oct 07, 2025

Raymond James Sticks to Its Buy Rating for Monopar Therapeutics Inc (MNPR)

TIPRANKS
·
Oct 06, 2025

Monopar Therapeutics Is Maintained at Outperform by Oppenheimer

Dow Jones
·
Oct 02, 2025

Monopar Therapeutics price target raised to $115 from $77 at Oppenheimer

TIPRANKS
·
Oct 02, 2025

Monopar Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Sep 29, 2025

Monopar Therapeutics price target raised to $105 from $70 at H.C. Wainwright

TIPRANKS
·
Sep 29, 2025

Monopar Therapeutics Inc. : H.c. Wainwright Raises Target Price to $105 From $70

THOMSON REUTERS
·
Sep 29, 2025

Major Shareholder Sells Massive Stake in Monopar Therapeutics!

TIPRANKS
·
Sep 27, 2025

Tactic Pharma LLC Reports Disposal of Monopar Therapeutics Inc. Common Shares

Reuters
·
Sep 27, 2025

Brookline Capital Markets Sticks to Its Buy Rating for Monopar Therapeutics Inc (MNPR)

TIPRANKS
·
Sep 26, 2025

Monopar Therapeutics Is Maintained at Buy by Chardan Capital

Dow Jones
·
Sep 25, 2025

Chardan Raises Price Target on Monopar Therapeutics to $85 From $60, Keeps Buy Rating

MT Newswires Live
·
Sep 25, 2025

Monopar Therapeutics Announces Underwriting Agreement for Stock Sale

TIPRANKS
·
Sep 25, 2025

U.S. RESEARCH ROUNDUP- Apogee Therapeutics, Intel, Northern Trust

Reuters
·
Sep 25, 2025

Monopar Therapeutics Inc : Btig Raises Target Price to $104 From $87

THOMSON REUTERS
·
Sep 25, 2025

Monopar Therapeutics Inc : Piper Sandler Raises Target Price to $95 From $76

THOMSON REUTERS
·
Sep 25, 2025

Positive Outlook for Monopar Therapeutics’ ALXN1840 Amid New Copper Balance Findings

TIPRANKS
·
Sep 25, 2025

Monopar Therapeutics price target raised to $104 from $87 at BTIG

TIPRANKS
·
Sep 25, 2025

BRIEF-Monopar Therapeutics Announces Pricing Of $135 Million Underwritten Offering Of Common Stock And Pre-Funded Warrants

Reuters
·
Sep 24, 2025